Pharmacokinetics - Pharmacodynamic Study of HT-2157 in Healthy Subjects and in Patients With Major Depressive Disorder

NCT01413932 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers (Part 1)
Major Depressive Disorder (Part 2)

Interventions

DRUG: HT-2157
DRUG: Placebo

Sponsor

Dart NeuroScience, LLC